Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $76.68 Analyst target: $118.00 Upside: 53.89%
IRADIMED CORPORATION develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories and services in the United States and internationally. The company is headquartered in Winter Springs, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.